Viewing Study NCT05359861

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:21 PM
Ignite Modification Date: 2026-01-03 @ 6:33 PM
Study NCT ID: NCT05359861
Status: COMPLETED
Last Update Posted: 2025-11-10
First Post: 2022-04-14
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma
Sponsor: Coherus Oncology, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Phase 2 View
None SRF388 View
None IL-27 View
None safety View
None efficacy View
None immunotherapy View
None cancer View
None immuno-oncology View
None liver cancer View
None hepatocellular carcinoma View
None atezolizumab View
None Tecentriq View
None bevacizumab View
None Avastin View